Physician profile
Iris A Seitz
NPI 1316197858
$3,716.18
in general payments reported to CMS, 2019-2025
25 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what 75% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $359 · 2021: $439 · 2022: $802 · 2023: $176 · 2024: $166 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470 · Travel and Lodging: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.09 |
| Travel and Lodging | $115.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $930.30 | 2022-2025 | Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $909.64 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $631.91 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $267.91 | 2021 | |
| Urgo Medical North America, LLC | $150.69 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ethicon US, LLC | $111.50 | 2020 | |
| Apyx Medical Corporation | $99.26 | 2019 | |
| Kci USA, INC. | $84.28 | 2019-2022 | |
| Tei Biosciences INC | $65.61 | 2019 | |
| Misonix INC | $63.04 | 2019-2020 | |
| Davol INC. | $61.04 | 2022-2025 | Arista |
| Polynovo North America LLC | $39.07 | 2024 | Novosorb Btm |
| Sientra, INC. | $39.02 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $34.83 | 2019 | |
| Stryker Corporation | $26.83 | 2024 | 1788 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $26.58 | 2021-2022 | |
| Solventum Corporation | $24.95 | 2025 | V.A.C.Ulta, Prevena |
| Mimedx Group, INC. | $24.50 | 2025 | |
| Smith+Nephew, INC. | $22.94 | 2020 | |
| W. L. Gore & Associates, INC. | $22.74 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.49 | 2019 | |
| Medline Industries Lp | $21.14 | 2019 | |
| Coopersurgical, INC. | $12.45 | 2019 | |
| Integra Lifesciences Corporation | $12.35 | 2019 | |
| Allergan, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iris Seitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.